Fundraising FoxBiotech Startups
11,050 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
Continuity Biosciences develops adaptive precision drug-delivery platforms that combine engineering and biology to help therapies reach their intended targets more effectively. The company works across multiple therapeutic applications rather than a single drug or disease, bridging medtech and biotech.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Cornerstone Pharmaceuticals develops anti-metabolic cancer therapies and is testing its lead drug candidate, CPI-613 (devimistat), in combinations using preclinical cancer models.
0 investors
0 investors
0 investors
Cosmos Health manufactures and distributes generic pharmaceuticals, branded nutraceuticals, and biocides through a vertically integrated global healthcare operation, while also conducting research and development of innovative drugs, drug repurposing initiatives, and operating a telehealth platform.
0 investors
0 investors
Courage Therapeutics is a neuroendocrine biotech developing MC4R agonist drugs for genetic obesity; its lead candidate CTX-B is a weekly injectable targeting melanocortin-4 receptor haploinsufficiency (MC4R HI), a form of early-onset severe obesity with no approved targeted therapy. The company translates research on the melanocortin system into therapeutic candidates for patients with MC4R pathway-driven obesity in the US.
0 investors
32 Biosciences develops gastrointestinal therapeutics that target gut microbial and host-microbe biology, with a lead candidate aimed at preventing surgical site infections in high-risk GI surgery. It uses a functional metabolomics discovery platform to support biomarkers, patient stratification, and drug discovery.
0 investors
0 investors